NEURADIAB Trademark

Trademark Overview


On Wednesday, November 29, 2006, a trademark application was filed for NEURADIAB with the United States Patent and Trademark Office. The USPTO has given the NEURADIAB trademark a serial number of 77053255. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 12, 2015. This trademark is owned by Bradmer Pharmaceuticals, Inc.. The NEURADIAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
neuradiab

General Information


Serial Number77053255
Word MarkNEURADIAB
Filing DateWednesday, November 29, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 12, 2015
Registration Number3531554
Registration DateTuesday, November 11, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2007

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 12, 2015
Primary Code005
First Use Anywhere DateTuesday, April 29, 2008
First Use In Commerce DateTuesday, April 29, 2008

Trademark Owner History


Party NameDUKE UNIVERSITY
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27710

Party NameBradmer Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5H2V1
CA

Party NameBradmer Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5H2V1
CA

Party NameBradmer Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1A9
CA

Trademark Events


Event DateEvent Description
Friday, June 12, 2015CANCELLED SEC. 8 (6-YR)
Wednesday, July 27, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 11, 2008REGISTERED-PRINCIPAL REGISTER
Thursday, October 9, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, October 9, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 18, 2008STATEMENT OF USE PROCESSING COMPLETE
Monday, September 15, 2008USE AMENDMENT FILED
Thursday, September 18, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 15, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, April 1, 2008EXTENSION 1 GRANTED
Monday, March 17, 2008EXTENSION 1 FILED
Monday, March 17, 2008TEAS EXTENSION RECEIVED
Friday, March 14, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 18, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 26, 2007PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2007NOTICE OF PUBLICATION
Wednesday, April 18, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 18, 2007ASSIGNED TO LIE
Tuesday, March 27, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 26, 2007ASSIGNED TO EXAMINER
Monday, December 4, 2006NEW APPLICATION ENTERED IN TRAM